Source:http://linkedlifedata.com/resource/pubmed/id/11559210
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2001-9-17
|
pubmed:abstractText |
There are 3 new topical treatments for herpes labialis that have either been approved by the US Food and Drug Administration (penciclovir cream [Denavir] and n-docosanol cream [Abreva]) or recently undergone extensive clinical evaluation (acyclovir cream). The relative efficacy of these products is unknown.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0003-987X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
137
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1153-8
|
pubmed:dateRevised |
2008-6-2
|
pubmed:meshHeading |
pubmed-meshheading:11559210-Acyclovir,
pubmed-meshheading:11559210-Administration, Topical,
pubmed-meshheading:11559210-Animals,
pubmed-meshheading:11559210-Disease Models, Animal,
pubmed-meshheading:11559210-Fatty Alcohols,
pubmed-meshheading:11559210-Female,
pubmed-meshheading:11559210-Guinea Pigs,
pubmed-meshheading:11559210-Herpes Labialis,
pubmed-meshheading:11559210-Herpesvirus 1, Human,
pubmed-meshheading:11559210-Humans,
pubmed-meshheading:11559210-Treatment Outcome
|
pubmed:year |
2001
|
pubmed:articleTitle |
Comparison of new topical treatments for herpes labialis: efficacy of penciclovir cream, acyclovir cream, and n-docosanol cream against experimental cutaneous herpes simplex virus type 1 infection.
|
pubmed:affiliation |
Department of Medicine, School of Medicine, Room 4B319, University of Utah, 50 North Medical Dr, Salt Lake City, UT 84132, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|